Tonix Pharmaceuticals Holding Corp. (TNXP) › RevenueTonix Pharmaceuticals Holding Corp. (TNXP) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $7.77M2024: $10.09M2025: $13.11M$13.11M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$13.11M+29.8%2024$10.09M+29.9%2023$7.77M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share